Asthma Clinical Trial
Official title:
The Talking Card for Asthma: A Recordable Audio Discharge Instruction Device to Improve Asthma Control
The research goal is to explore the use and effects of a custom-recordable audio discharge
instruction card (Talking Card) in the pediatric health care setting. This study will
address a primary, experimental research question: can pediatric asthma control be improved
through the distribution of a custom-recorded audio asthma instruction card to parents at
the health provider's office? Secondary, descriptive objectives will be to evaluate
feasibility of Talking Card delivery and to collect and summarize parental reactions to the
design and use of the audio discharge instruction card.
The specific aims of this study are:
1. To compare the change in mean Childhood Asthma Control Test (C-ACT) scores for children
aged 4 through 11 years with uncontrolled asthma receiving a custom-recorded asthma
instruction card to the change in mean C-ACT scores for those receiving usual care.
2. To measure the use and impressions of a custom-recordable audio asthma discharge
instruction card among primary caregivers of children with uncontrolled asthma through
quantitative and qualitative survey questions.
The investigators hypothesize that:
1) Asthma control in children 4 through 11 years of age with uncontrolled asthma, as
measured by the C-ACT, will improve to a greater extent among those receiving a
custom-recordable audio discharge instruction card than among those receiving usual care.
| Status | Completed |
| Enrollment | 64 |
| Est. completion date | October 2012 |
| Est. primary completion date | October 2012 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 4 Years to 11 Years |
| Eligibility |
Inclusion Criteria: - Child age 4 through 11 years old - English-speaking primary caregiver - Enrollment in Medicaid insurance company within 12 months of study recruitment (original Kansas City site criterion, removed on revision) - Diagnosis of asthma (ICD-9 code 493.0) within 12 months of study recruitment - Visit to study site clinic for asthma within 12 months of study recruitment Exclusion Criteria: - History of premature birth less than 33 weeks gestation or requirement of a significant level of respiratory care including mechanical ventilation as a neonate - Any major chronic illness including but not limited to non-skin cancer, cystic fibrosis, bronchiectasis, sickle cell anemia, endocrine disease, congenital heart disease, congestive heart failure, stroke, severe hypertension, insulin-dependent diabetes mellitus, renal failure, liver disorders, immunodeficiency states, significant neuro-developmental delay or behavioral disorders (excluding mild attention deficit hyperactivity disorder), or other conditions that would interfere with participation in the study - Visit to any primary care provider giving asthma action plan advice during the previous month - Anticipated departure from study area before study period ends (3-month follow-up) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Country | Name | City | State |
|---|---|---|---|
| United States | Children's Mercy Hospital | Kansas City | Missouri |
| United States | University of South Florida | Tampa | Florida |
| Lead Sponsor | Collaborator |
|---|---|
| Children's Mercy Hospital Kansas City | University of South Florida |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Asthma Control (C-ACT) | Childhood Asthma Control Test (C-ACT) score, measured repeatedly across 3 visits | 3 months | No |
| Secondary | Parental Card Use and Satisfaction | Survey of parental card use and satisfaction with card performance, measured repeatedly across 3 visits | 3 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|